NCT07310992

Effect of Meditation as an Adjunct to Cardiac Rehabilitation

Not yet recruiting NA Last updated 5 January 2026

What this trial tests

NA trial testing Meditation in High Blood Pressure (& [Essential Hypertension]) in 80 participants. Not yet recruiting.

Timeline

15 January 2026

Primary endpoint
15 January 2027

15 January 2028

Quick facts

Lead sponsor	Instituto Dante Pazzanese de Cardiologia
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	80
Start date	15 January 2026
Primary completion	15 January 2027
Estimated completion	15 January 2028

Drugs / interventions tested

• Meditation
• Standard Cardiac Rehabilitation

Conditions studied

• High Blood Pressure (& [Essential Hypertension]) — all drugs for High Blood Pressure (& [Essential Hypertension]) →
• Meditation Training — all drugs for Meditation Training →
• Rehabilitation Exercise — all drugs for Rehabilitation Exercise →

Sponsor

Instituto Dante Pazzanese de Cardiologia — full company profile →

Who can join

18 and older, any sex, with High Blood Pressure (& [Essential Hypertension]) or Meditation Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiovascular rehabilitation is a well-established standard of care that significantly reduces morbidity and mortality while improving quality of life. However, integrating behavioral interventions into physical training may offer additional benefits for autonomic regulation and emotional well-being.

This randomized clinical trial aims to investigate the efficacy of adding a brief, guided mindfulness meditation session to a standard cardiovascular rehabilitation program. The study seeks to determine whether this combined intervention enhances blood pressure control, improves perceived quality of life, and increases patient adherence compared to standard rehabilitation alone.

Participants newly enrolled in the Cardiac Rehabilitation Service will be randomized into two groups. Both groups will undergo a standard 12-week regimen of aerobic and resistance training combined with optimized medical therapy. The intervention group will additionally receive 15 minutes of voice-guided mindfulness meditation at the end of each exercise session. Key outcome measures include blood pressure variability, quality of life scores (assessed via EQ-5D), and attendance rates.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.